Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy
β Scribed by J.-J. Lee; C.-E. Nam; S.-H. Cho; K.-S. Park; I.-J. Chung; H.-J. Kim
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 162 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
From the Departments of Haematology and Oncology, the Hospital for Sick Children, Great Ormond Street, London (A.M.),
The objective of this study was to develop and test a combined therapeutic approach for patients with AIDS-related lymphoma (ARL), employing agents with independent mechanisms of action and nonoverlapping toxicity. This study was designed to test the feasibility and tolerance of combining low dose c
## Abstract The prognosis of relapsing Hodgkin's disease (HD) and high grade aggressive nonβHodgkin's lymphoma (NHL) is generally poor since many of these patients fail to respond to second line chemotherapy. Radiation therapy has been reported as an effective but seldom used, alternative treatment